
A group of 9 experts reflect on what they are looking forward to most in 2025 following the AAD annual meeting.

Robert Bissonnette, MD, is the chairman at Innovaderm Research.

A group of 9 experts reflect on what they are looking forward to most in 2025 following the AAD annual meeting.

Robert Bissonnette, MD, discusses data from the ICONIC-LEAD trial and the potential role of icotrokinra in plaque psoriasis.